In Finance

An emerging CBD company Heavenly Rx, a subsidiary of SOL Global Investments, plans to take over a Nasdaq-traded pharmaceutical corporation, Therapix Biosciences Ltd (NASDAQ: TRPX), focused on developing cannabinoid pharmaceuticals.

Recent Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search